Teachers Retirement System of The State of Kentucky Takes Position in Medline $MDLN

Key Points

• Teachers Retirement System of The State of Kentucky bought a new stake of 65,900 shares (~$2.77M) in Medline during Q4, and other institutions including Vanguard, Baillie Gifford and MFS also established large new positions, signaling broad institutional interest.
• Analysts have grown bullish—Morgan Stanley and RBC raised targets and ratings, Citi and William Blair initiated coverage with buy/outperform calls, and MarketBeat reports a consensus rating of "Moderate Buy" with a $50.62 target.
• Medline posted a quarterly revenue beat of $7.79B (up 14.8% YoY) but missed EPS estimates (‑$0.01 vs $0.24 expected); shares trade around $45, near their 50‑day average and within a 12‑month range of $34.89–$50.88.

Teachers Retirement System of The State of Kentucky purchased a new stake in shares of Medline (NASDAQ:MDLN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 65,900 shares of the company's stock, valued at approximately $2,768,000.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. purchased a new position in Medline during the 4th quarter valued at about $793,278,000. Baillie Gifford & Co. purchased a new stake in shares of Medline in the fourth quarter worth approximately $437,236,000. Massachusetts Financial Services Co. MA acquired a new stake in shares of Medline during the fourth quarter worth approximately $429,544,000. Mass General Brigham Inc acquired a new stake in shares of Medline during the fourth quarter worth approximately $1,104,000. Finally, SteelPeak Wealth LLC purchased a new position in Medline during the fourth quarter valued at approximately $441,000.

Analyst Upgrades and Downgrades

MDLN has been the subject of a number of research analyst reports. Morgan Stanley increased their target price on shares of Medline from $48.00 to $52.00 and gave the stock an "overweight" rating in a research report on Monday, March 2nd. Royal Bank Of Canada boosted their price target on shares of Medline from $47.00 to $53.00 and gave the company an "outperform" rating in a report on Thursday, February 26th. Citigroup assumed coverage on shares of Medline in a research note on Wednesday, March 11th. They issued a "buy" rating and a $60.00 price target on the stock. William Blair assumed coverage on Medline in a report on Monday, January 12th. They set an "outperform" rating for the company. Finally, Deutsche Bank Aktiengesellschaft began coverage on Medline in a research note on Monday, January 12th. They issued a "hold" rating and a $40.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Medline presently has a consensus rating of "Moderate Buy" and a consensus target price of $50.62.

Medline Trading Up 1.0%

Shares of MDLN opened at $45.19 on Tuesday. The business's fifty day simple moving average is $45.00. Medline has a 12 month low of $34.89 and a 12 month high of $50.88.

Medline (NASDAQ:MDLN - Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.25). The company had revenue of $7.79 billion for the quarter, compared to analyst estimates of $7.52 billion. Medline's revenue for the quarter was up 14.8% on a year-over-year basis. Equities research analysts forecast that Medline will post 1.46 earnings per share for the current fiscal year.

Medline Profile

Medline NASDAQ: MDLN is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.